Devyser Diagnostics AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0016588867
SEK
77.60
-0.2 (-0.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
72.00
56.40
67.40
54.80
64.20
48.70
53.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
72.00
56.40
67.40
54.80
64.20
48.70
53.20
Raw Material Cost
14.80
14.10
10.60
9.10
10.00
13.50
10.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.10
1.20
3.70
0.80
1.20
0.90
0.90
Selling and Distribution Expenses
36.60
37.40
46.20
53.10
49.70
46.80
49.50
Other Expenses
0.03
0.23
0.13
0.62
0.81
0.82
1.43
Total Expenditure (Excl Depreciation)
53.80
55.00
61.80
69.20
69.00
69.40
75.40
Operating Profit (PBDIT) excl Other Income
18.2
1.4000000000000001
5.6000000000000005
-14.399999999999999
-4.8
-20.7
-22.200000000000003
Other Income
0.00
0.00
0.10
-5.60
5.50
-2.10
0.50
Operating Profit (PBDIT)
25.20
8.20
11.00
-14.70
6.80
-17.00
-16.10
Interest
2.10
1.20
3.70
0.80
1.20
0.90
0.90
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
57.20
42.30
56.80
45.70
54.20
35.20
42.50
Depreciation
7.00
6.80
5.30
5.30
6.10
5.80
5.60
Profit Before Tax
16.00
0.20
2.00
-20.90
-0.50
-23.50
-22.60
Tax
2.40
3.00
0.70
-0.40
2.70
-0.30
0.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13.60
-2.80
1.30
-20.50
-3.20
-23.20
-22.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13.60
-2.80
1.30
-20.50
-3.20
-23.20
-22.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13.60
-2.80
1.30
-20.50
-3.20
-23.20
-22.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Reserves
354.30
341.00
338.00
330.40
349.00
349.00
367.90
Earnings per share (EPS)
0.81
-0.17
0.08
-1.24
-0.19
-1.41
-1.4
Diluted Earnings per share
0.81
-0.17
0.08
-1.24
-0.19
-1.41
-1.4
Operating Profit Margin (Excl OI)
25.28%
2.48%
8.31%
-26.28%
-7.48%
-42.51%
-41.73%
Gross Profit Margin
31.94%
12.41%
10.83%
-28.47%
8.72%
-36.34%
-31.95%
PAT Margin
18.89%
-4.96%
1.93%
-37.41%
-4.98%
-47.64%
-43.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 27.66% vs -16.32% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 585.71% vs -315.38% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 207.32% vs -24.77% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 75.00% vs -67.57% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Devyser Diagnostics AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
72.00
4.50
67.50
1,500.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
72.00
4.50
67.50
1,500.00%
Raw Material Cost
14.80
46.70
-31.90
-68.31%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.10
9.00
-6.90
-76.67%
Selling and Distribution Expenses
36.60
0.00
36.60
Other Expenses
0.03
0.84
-0.81
-96.43%
Total Expenditure (Excl Depreciation)
53.80
64.10
-10.30
-16.07%
Operating Profit (PBDIT) excl Other Income
18.20
-59.60
77.80
130.54%
Other Income
0.00
-3.50
3.50
100.00%
Operating Profit (PBDIT)
25.20
-22.60
47.80
211.50%
Interest
2.10
9.00
-6.90
-76.67%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
57.20
-42.20
99.40
235.55%
Depreciation
7.00
40.50
-33.50
-82.72%
Profit Before Tax
16.00
-72.10
88.10
122.19%
Tax
2.40
3.50
-1.10
-31.43%
Provisions and contingencies
0
0
0.00
Profit After Tax
13.60
-75.60
89.20
117.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
13.60
-75.60
89.20
117.99%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13.60
-75.60
89.20
117.99%
Equity Capital
0
0
0.00
Face Value
0.06
0.50
0.00
Reserves
354.30
1,971.50
-1,617.20
-82.03%
Earnings per share (EPS)
0.81
-0.07
0.88
1,257.14%
Diluted Earnings per share
0.81
-0.07
0.88
1,257.14%
Operating Profit Margin (Excl OI)
25.28%
-1,324.44%
0.00
1,349.72%
Gross Profit Margin
31.94%
-702.22%
0.00
734.16%
PAT Margin
18.89%
-1,680.00%
0.00
1,698.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 27.66% vs -16.32% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 12.15% vs 41.41% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.36 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 585.71% vs -315.38% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 525.00% vs 75.57% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.52 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 207.32% vs -24.77% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 1,838.46% vs 111.02% in Dec 2024

Quarterly - Interest
Interest 0.21 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 75.00% vs -67.57% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 75.00% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.28%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024